XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Tables)

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Stock Based Compensation

Weighted Average Assumptions


		Three Months Ended March 31,
		2022		2021
Dividend yield		0	%	0	%
Expected volatility		70	%	98	%
Risk-free interest rate		1.89	%	0.71	%
Expected term		5.66 years		5.61 years

Stock Option Activity


					Weighted			Weighted
					Average			Average			Aggregate
					Exercise			Contractual			Intrinsic
		Number of			Price			Term			Value
		shares			Per Share			(in years)			(in thousands)
Outstanding at January 1, 2022			1,911,177		$	20.64			6.33		$	15,103
Granted			160,000			20.60
Exercised			(90,811)			6.97
Forfeited, expired or cancelled			(6,215)			27.83
Outstanding at March 31, 2022			1,974,151		$	21.25			6.44		$	24,090
Exercisable at March 31, 2022			1,522,824		$	19.70			5.60		$	22,139

Stock-based Compensation Expense

The following table shows total stock-based compensation expense for stock options and ESPP in the condensed consolidated statements of operations and comprehensive loss (in thousands):


		Three Months Ended March 31,
		2022			2021
Research and development		$	—		$	—
General and administrative			978			2,898
Total stock-based compensation expense		$	978		$	2,898